News on the Division of Blood Diseases and Resources
|
Research Feature
NHLBI study assesses health of residents in rural South for heart, lung disease Adults in the rural South region, which includes Appalachia and the Mississippi Delta, have some of the highest rates of heart disease, obesity, high blood pressure, and chronic obstructive pulmonary disease (COPD) in the country. Heart failure rates, for example, are...
|
Research Features
The U.S. Food and Drug Administration approved two new gene therapies to treat sickle cell disease — one a gene-editing and the other a gene-addition approach. Nearly 100,000 people in the United States — and millions worldwide — have been diagnosed with this painful, life-threatening genetic blood disease. To help explain the historic importance...
|
News Release
Findings highlight insufficient sleep as a modifiable risk factor for type 2 diabetes Chronic insufficient sleep can increase insulin resistance in otherwise healthy women, with more marked effects in postmenopausal women, according to a study funded by the National Institutes of Health. The findings, published in Diabetes Care, highlight the...
Findings suggest potential benefit of giving more blood to patients A National Institutes of Health supported study found that the type of transfusion approach used to support adults who developed anemia after a heart attack did not make a significant difference in their likelihood of having another heart attack or dying within 30 days...
|
Research Feature
ACTIV-4 research has provided clinicians with guidance for treating and reducing risks for severe COVID outcomes related to inflammation and blood clotting When SARS-CoV-2, the virus that causes COVID-19 , first emerged in late 2019, researchers quickly assembled to understand its effects and figure out how to stop its spread. Soon, late-night...
|
NHLBI in the Press
When it comes to convalescent plasma for the treatment of COVID-19, early intervention appears to make a difference for some outpatients.
|
NHLBI in the Press
Nearly 90% of COVID-19 patients who qualified for but did not receive ECMO (extracorporeal membrane oxygenation) due to a shortage of devices during the pandemic died in the hospital.